The total return over the past 12 months is -47.42% vs. +16.94% for the S&P 500. So far it's up -25.16% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (47.42%) | (36.23%) | (44.43%) | N/A | N/A | N/A |
| Total Return CAGR | (47.42%) | (36.23%) | (44.43%) | N/A | N/A | N/A |
| Revenue CAGR | +10.02% | (11.03%) | (2.03%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Caribou Biosciences, Inc. (CRBU)
| Year | Start price | End price | CRBU Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.59 | $1.19 | (25.16%) | +14.51% | (39.67%) |
| 2025 | $1.59 | $1.59 | 0.00% | +17.72% | (17.72%) |
| 2024 | $5.73 | $1.59 | (72.25%) | +24.89% | (97.14%) |
| 2023 | $6.28 | $5.73 | (8.76%) | +26.19% | (34.95%) |
| 2022 | $15.09 | $6.28 | (58.38%) | (18.17%) | (40.21%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
